Point-of-care tests are simple medical tests
performed at the bedside or at the clinical laboratory in close immediacy to
where the patient is receiving care. It is mainly powered by high-quality and
cost-effective medical solutions & technological advancement. It may
enhance the management of different diseases & conditions. It is usually
performed by non-laboratory persons and results are used for clinical decision
making. It is frequently accomplished through the use of portable,
transportable, and handheld instruments (nerve conduction study device and
blood glucose meter) and test kits (Homocystein, HBA1C, HIV salivary assay,
etc.).
According to study, “Global
Point of care testing Market Size study, by product (Glucose Monitoring
Products, Infectious Disease Testing Products, Cardiometabolic Testing
Products, Pregnancy & Fertility Testing Products, Coagulation Testing
Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility
Testing Products, Cholesterol Testing Products, Urinalysis Testing Products,
Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult
Testing Products and other POC products ), Platform (Microfluidics, Lateral
Flow Assays, Dipsticks, immunoassays, molecular diagnostics) , Mode (OTC-based
testing and prescription-based testing) End-user (research laboratories, home
care, professional diagnostics centers and other end-users) and Regional
Forecasts 2018-2025” the key companies operating in the global point of care
testing market are EKF Diagnostics, Johnson & Johnson, Abbott Laboratories,
Becton, Dickinson and Company, Accubiotech, Siemens Healthineers, Danaher
Corporation, Roche Diagnostics, Quest Diagnostic, Siemens.
Based on product, point of care testing market
is segmented into cardio-metabolic monitoring products, glucose monitoring
products, infectious disease testing products, pregnancy & fertility
testing products, coagulation monitoring products, urinalysis testing products,
tumor or cancer market testing products, cholesterol testing products, drugs-of-abuse
testing products, hematology testing products, fecal occult testing products
and others. Cardio-metabolic monitoring products include blood gas/electrolyte
testing products, cardiac marker testing products and Hba 1 c testing products.
Glucose monitoring products include meters, strips and lancets & lancing
devices. Infectious disease testing products include HIV testing products,
influenza testing products, healthcare associated infection testing products,
hepatitis C testing products, sexually transmitted disease testing products,
tropical disease testing products, respiratory infection testing products and
other infectious disease testing products. Pregnancy & fertility testing
products include fertility testing products and pregnancy testing products.
Additionally, coagulation monitoring products include Activated Clotting Time
(ACT/APTT) Testing Kits and Prothrombin Time (PT/INR) Testing Kits. Based on
mode of prescription, market is segmented intoC Over-the-ounter (OTC) products
and prescription based products. Based on distribution channel, market is
segmented into retail and direct tenders. In addition, based on end-user,
market is segmented into hospitals/critical care centers, professional
diagnostic centers, research laboratories, home care settings and others.
The point of care testing market is driven by
rise in incidence of target conditions, followed by high prevalence of
infectious diseases in developing countries, increase in international research
collaborations, shortage of skilled laboratory technicians, growth in
government support and rise in number of Clia-Waived POC tests. However,
stringent & time-consuming regulatory policies and lack of alignment with
definitive central lab methods may impact the market. Moreover, POC tests with
multiplexing capabilities and rise in awareness through conferences &
events are key opportunities for market.
Based on geography, the North-American region
holds the leading position in point of care testing market owing to rise in
healthcare expenditure and high awareness amongst healthcare providers &
patients regarding early disease diagnosis in the region. Whereas, the
Asian-Pacific region is estimated to witness higher growth rate due to growth
in companies engaged in exploiting the untapped opportunities over the forecast
period.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249